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Abstract
Objectives: To address molecular mechanisms underlying obesity development, we examined patterns of critical
metabolism-related hormones, adiponectin and leptin (adipokines), over childhood.
Subjects and Design: Plasma adiponectin and leptin were measured in 80 Mexican-American children at birth and again at
2, 5, and 9 years from the ongoing prospective cohort followed by the Center for the Health Assessment of Mothers and
Children of Salinas (CHAMACOS). We used a mixture modeling approach to identify patterns in adipokine trajectories from
birth to 9 years.
Results: Leptin was positively related to child body size within all ages, however adiponectin had inverse and weaker
associations with BMI at 2, 5, and 9 years. Correlations between adipokine levels over the 0–2, 2–5, and 5–9-year periods
increased for both leptin (r = 0.06, 0.31 and 0.62) and adiponectin (r = 0.25, 0.41 and 0.46). Our mixture modeling approach
identified three trajectory clusters for both leptin (1L [slowly-rising], 2L [rapidly-rising], and 3L [stable]) and adiponectin (1A
[steep-dropping and rebounding], 2A [moderately-dropping], and 3A [stable]). While leptin groups were most separated
over the 2–9-year period, adiponectin trajectories displayed greatest heterogeneity from birth to 2 years. Children in the
rapidly-rising 2L group had highest BMI and waist circumference at 9 years. Further, children with greater birth weight had
increased odds of belonging to this high risk group (OR= 1.21 95% CI 1.03, 1.43, compared to stable group 3L). Children
whose mothers consumed more sugar-sweetened beverages during pregnancy were at risk of being in the steep-dropping
1A group (OR = 1.08, 95% CI 1.01, 1.17, compared to stable group 3A).
Conclusion: Our results highlight developmental differences in leptin and adiponectin over the childhood period. Leptin
closely reflects child body size however factors affecting adiponectin and long-term consequences of its changes over
infancy need to be further explored.
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Introduction
Recent data show that children may follow different growth
patterns and that those who display excessively rapid body mass
index (BMI) gains may be at higher risk for adult obesity and
adverse metabolic health [1–5]. However, longitudinal data
demonstrating changes in critical energy balance hormones, such
as adiponectin and leptin (commonly termed adipokines), are
limited. Examining adipokine trajectories over childhood may
help shed further light on obesity etiology and heterogeneity of
growth patterns.
Adiponectin, a protein hormone secreted by adipose tissue,
targets muscle and liver to increase uptake and catabolism of fatty
acids and carbohydrates, promoting insulin sensitivity [6]. In
children, lower adiponectin levels are associated with both
metabolic syndrome and type 2 diabetes [7,8]. Further, while
there is a well-established inverse relationship between adiponectin
and BMI in school-age children, this relationship is less clear in
newborns. Several studies report a positive relationship between
adiponectin and birth weight but others do not [9–12].
Leptin, a hormone synthesized primarily by adipose tissue but
also by the stomach, skeletal muscle and liver, acts on the
hypothalamus to convey satiety and regulate long-term energy
balance [13,14]. Plasma leptin levels correlate positively with
adiposity in newborns, children and adults [15,16]. However,
obese individuals commonly develop ‘leptin resistance’ or toler-
ance – a hyperleptinemic state characterized by decreased
responsiveness to leptin [15].
An important and yet relatively unaddressed question is
whether early life adipokine measures predict future adipokine
levels and obesity-related outcomes. Only two prospective cohorts
have explicitly examined such associations, both over a relatively
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narrow age range [17,18]. Data from Project Viva (N= 588)
showed that cord blood adiponectin was positively related to
central obesity (p = 0.04) but not with adiponectin at 3 years [17].
Cord blood leptin was negatively related to BMI (p,0.001) and
positively related to leptin (p = 0.001) at 3 years. Additionally, a
report on older children (N= 519) showed that adiponectin and
leptin in 9 to 10-year-olds were directly and significantly correlated
with their respective adipokine levels, three years later (p,0.001
for both) [18]. While there is some evidence that early and later life
adipokine levels are associated, it is unclear whether such
relationships hold over the childhood period.
Emerging data show that the perinatal environment may
influence adipokine trajectories. We have previously shown that
greater rate of weight and length gain in the first 6 months of life is
negatively associated with 9-year adiponectin levels, adjusting for
concurrent child BMI [19]. Further, maternal nutrition, gesta-
tional diabetes, weight gain during pregnancy and child birth
weight have been previously identified as risk factors for obesity
and adverse metabolic health in later life, but their relationship
with child adipokines remains poorly understood [1–3,20–22].
To address current data gaps on adipokine development over
childhood, we measured adiponectin and leptin levels in a
prospective cohort of children at birth, 2, 5, and 9 years. We
determined their associations between time points and with child
BMI at each age. Further, using a mixture modeling approach, we
identified groups of children with distinct adipokine trajectories
and examined whether demographic, fetal growth and dietary
factors are associated with these groups. Analyses were performed
using data from the Center for the Health Assessment of Mothers
and Children of Salinas (CHAMACOS), a Mexican-American
cohort with a high prevalence of child obesity [23,24].
Materials and Methods
Subjects and Study Design
The CHAMACOS study is a longitudinal birth cohort designed
to assess the health effects of pesticides and other exposures on
growth and development in children living in Salinas Valley, CA
[25,26]. Mothers were enrolled during pregnancy between
October 1999 and October 2000, with 537 mother-child pairs
in the study at delivery and 327 pairs remaining at the 9-year visit.
Eligible women were $18 years of age, ,20 weeks gestation at
enrollment, English or Spanish speaking, Medi-Cal eligible and
planning to deliver at the county hospital. Women were
interviewed at ,13 weeks gestation, ,26 weeks gestation, shortly
after delivery, and when their children were 6 months, and 1, 2,
3K, 5, 7, and 9 years of age. Developmental assessments of
children, including anthropometrics, were conducted at birth and
at the time of each maternal interview. Adiponectin and leptin
were measured on a convenience sample of 80 children having
blood samples at birth, 2, 5, and 9 years and complete
anthropometric and demographic data. No differences were
observed comparing maternal and child demographic and
Table 1. Demographic characteristics of mothers and
children from the CHAMACOS Study, Salinas Valley, CA
(N= 80).
Characteristic N (%)
Child sex
Boy 39 (49)
Girl 41 (51)
Child gestational age at birth
34–36 Weeks 4 (5)
$37 Weeks 76 (95)
Child birth size
Small for gestational age (,10th percentile) 5 (6)
Appropriate for gestational age 70 (88)
Large for gestational age (.90th percentile) 5 (6)
Child BMI1 at 9 years
Normal (#85th percentile) 37 (46)
Overweight (.85th, ,95th percentile) 17 (21)
Obese ($95th percentile) 26 (33)
Maternal age at pregnancy
18–24 39 (49)
25–29 22 (27)
30–34 15 (19)
35–45 4 (50
Maternal years in US at pregnancy
,1 20 (25)
1–10 40 (50)
.10 20 (25)
Maternal education at pregnancy
#6th Grade 33 (41)
7–12 Grade 34 (43)
$High School 13 (16)
Household poverty category at pregnancy
#Poverty threshold 45 (56)
.Poverty level but ,200% poverty level 32 (40)
$200% Poverty level 3 (4)
Maternal pre-pregnancy BMI
Normal (18.5–24.9 kg/m2) 36 (45)
Overweight (25–29.9 kg/m2) 28 (35)
Obese ($30 kg/m2) 16 (20)
1Child’s weight status was determined using age and sex adjusted body mass
index cut offs for 85th and 95th percentiles from CDC child growth charts.
doi:10.1371/journal.pone.0077964.t001
Table 2. Relationship between adiponectin, leptin, and size
(birth weight and BMI) in children from birth to 9 years of age
(N= 80).
Beta1 (p) r2
Birth Weight - A0 0.01 (0.47) 0.08
BMI2 - A2 22.91 (0.03) 20.24
BMI5 - A5 22.33 (0.01) 20.28
BMI9 - A9 22.06 (,0.001) 20.42
Birth Weight - L0 0.001 (,0.001) 0.46
BMI2 - L2 0.05 (,0.001) 0.52
BMI5 - L5 0.07 (,0.001) 0.73
BMI9 - L9 0.09 (,0.001) 0.78
A - adiponectin, L - log10(leptin). BMI - body mass index (kg/m
2).
A0, L0 - at birth, A2, L2 - at 2 years, A5, L5 - at 5 years, A9, L9 - at 9 years.
1Linear regression coefficient.
2Pearson’s correlation coefficient.
doi:10.1371/journal.pone.0077964.t002
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PLOS ONE | www.plosone.org 2 October 2013 | Volume 8 | Issue 10 | e77964
anthropometric measures between this sub-sample and the overall
CHAMACOS cohort.
Ethics Statement
We obtained signed informed consent from all women at the
time of enrollment in the study. All study procedures were
approved by the Committee for the Protection of Human Subjects
at the University of California, Berkeley. IRB Protocol 2010-03-
949.
Questionnaire Data
Sociodemographic information, including maternal age at
pregnancy, years of living in US prior to pregnancy, education,
and household poverty category was gathered during the first
prenatal interview at 1465 weeks gestation. Interviews were
conducted in Spanish or English by bilingual, bicultural trained
interviewers. Maternal pre-pregnancy BMI was calculated using
the mother’s self-reported pre-pregnancy weight and measured
height. During the second prenatal interview at 2663 weeks
gestation we used a previously validated food frequency question-
naire (FFQ) to assess maternal sugar-sweetened beverage con-
sumption [27,28]. In brief, participant mothers were asked to
report number of drinks in the last 3 months of 100% orange,
grapefruit, apple, grape, or other real 100% fruit juice; fruit drinks
(Tampico, Sunny D, lemonade, Kool-Aid); or non-diet soda
(recoded as drinks per week). This FFQ is based on the Spanish-
language Block 98 Questionnaire and was modified for use in the
CHAMACOS Mexican-American population [27]. Additional
details on the FFQ used here are available in Harley et al [28].
Data on maternal weight at delivery, infant birth weight, length,
and gestational age were obtained from delivery medical records
abstracted by a registered nurse. Children were categorized as
‘small for gestational age’ (SGA) if their birth weight was ,10th
percentile for gestational age, controlling for ethnicity, parity and
infant sex from national data [29]. They were categorized as ‘large
for gestational age’ (LGA) if their birth weight was .90th
percentile. Children were considered as ‘at term’ if they were
born at or after 37 weeks of gestation. Gestational weight gain was
calculated as mother’s weight at delivery from medical records
minus self-reported pre-pregnancy weight. Associations between
maternal smoking and adipokines were not examined as 76 of the
80 mothers reported no use of tobacco at the prenatal visits.
Anthropometric Measurements
Children’ weight and height were measured at the 2, 5, and 9-
year visits using a calibrated electronic scale (Tanita Mother-Baby
Scale Model 1582, Tanita Corp.) and stadiometer, respectively.
Child height was measured in triplicate and the average of
measurements was used. Child waist circumference was measured
at the 9-year-visit with a tape placed above the crest of the ileum.
Measurements were recorded to the nearest 0.1 cm after the child
exhaled, performed in triplicate and the average of the measures
was used. BMI was calculated as mass in kilograms divided by
height in meters squared. Children were categorized as normal
weight, overweight or obese using the sex and age-specific BMI
cut-offs (85th and 95th percentile, respectively) provided by the
2000 Centers for Disease Control and Prevention (CDC) child
growth data. Mothers were categorized as normal weight (18.5–
24.9 kg/m2), overweight (25–29.9 kg/m2) or obese ($30 kg/m2)
using the standard CDC BMI cutoffs for adults.
Plasma Adiponectin and Leptin Measurements
Adiponectin and leptin were measured in banked blood plasma
samples stored at 280uC using enzyme-linked immunoassay
(ELISA) RayBio Human Adiponectin and Human Leptin kits
(Norcross, GA). The minimum detectable concentrations for
adiponectin and leptin ELISAs were 10 pg/ml and 6 pg/ml
respectively. All samples were run in duplicate and the values were
averaged. The intra- and inter-plate coefficients of variance (CV)
were 3% and 12%, respectively, for adiponectin and 3% and 13%,
respectively, for leptin.
Statistical Analyses
Adiponectin levels were approximately normally distributed,
but leptin levels were right-skewed at all four time points. Thus, all
leptin-based analyses use base-ten log-transformed values. We
used Pearson’s correlation coefficient and linear regression to
determine both associations between adipokines measured at
different time points and associations between adipokine levels and
child anthropometry.
To explore whether there are distinct adipokine trajectory
groups, we used vertically-shifted mixture modeling (VSMM). This
method is an extension to Gaussian mixture modeling, which is the
basis of group-based trajectory modeling (GBTM) and growth
mixture models (GMM) and focuses on clustering trajectories
based on their shape over time [30–32]. A detailed description of
this approach is provided in Heggeseth et al [33]. In brief, this
method removes individual level means and assumes that within
each group, 1) mean adipokine trajectories follow a piecewise
polynomial function of time based on a 3rd order B-spline with one
knot at the median time, and 2) an exponential working variance-
covariance matrix for the repeated adipokine measurements
within participants. Overall, this approach seeks to identify mean
patterns of adipokine trajectories and assigns individuals to these
groups based on highest posterior probabilities using the
expectation-maximization (EM) algorithm.
Best fit was assessed comparing the Bayesian information
criterion (BIC) for 1 to 5 group models. Group membership was
simultaneously modeled using a generalized logit function to
estimate odds ratios (ORs) of group membership as a function of
early life variables. Pearson’s correlation and linear regression
analyses were conducted using STATA 12 (College Station, TX)
Table 3. Associations within adipokines in children over the
birth - 9-year period (N = 80).
A2 A5 A9
Beta1 (p) r2 Beta (p) r Beta (p) r
A0 0.14 (0.03) 0.25 0.17 (0.003) 0.33 0.12 (0.05) 0.22
A2 0.38 (,0.001) 0.41 0.46 (,0.001) 0.48
A5 0.49 (,0.001) 0.46
L2 L5 L9
Beta (p) r Beta (p) r Beta (p) r
L0 0.03 (0.58) 0.06 0.12 (0.08) 0.20 0.24 (0.09) 0.19
L2 0.45 (0.004) 0.31 0.63 (0.05) 0.22
L5 1.26 (,0.001) 0.62
A - adiponectin, L - log10(leptin).
A0, L0 - at birth, A2, L2 - at 2 years, A5, L5 - at 5 years, A9, L9 - at 9 years.
1Linear regression coefficient.
2Pearson’s correlation coefficient.
doi:10.1371/journal.pone.0077964.t003
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for Windows. All mixture modeling analyses were performed using
R statistical software (R Foundation for Statistical Computing,
Vienna, Austria). P-values ,0.05 were considered statistically
significant.
Results
Maternal and Child Characteristics
Of the 80 children in this study, there were a similar number of
boys (N= 39) and girls (N= 41) (Table 1). Children were delivered
primarily at term ($37 weeks, 95%) and were appropriate for
gestational age (88%). Very few children were small for gestational
age (,10th percentile, 6%) or large for gestational age (.90th
percentile, 6%). At 9 years, the majority of children were
overweight or obese (54%). At time of pregnancy, mothers tended
to be young (25.6 years), have resided in the US 10 years or less
(75%) and have low educational attainment (41% with #6th
grade). Additionally, more than half of the families (56%) were
living at or below the federal threshold for poverty. Based on pre-
pregnancy BMI, 55% of mothers were overweight or obese.
Child Adipokines by Age and Gender
Children had highest levels of adiponectin at birth (mean6SD,
112.8635.1 mg/ml), with a subsequent decrease to lower values at
2 years of age (51.3620.4 mg/ml) (Table S1). Adiponectin levels
continued to decrease, however not as sharply, until 5 years
(41.9618.5 mg/ml), and remained similar at 9-years
(42.5619.6 mg/ml). Adiponectin did not differ between boys and
girls at any of the time points assessed. Child log(leptin) decreased
from initially high levels at birth (1.0860.37) to lower levels at 2
years of age (0.4260.16). At the following time points, there was a
small but significant increase to 5-year levels (0.4960.23), and a
sharper increase to higher leptin in 9-year-olds (0.8960.47). Girls
had higher levels of leptin compared to boys at birth and at 5 years
(p,0.001, p = 0.01, respectively), but only the difference at birth
persisted after adjustment for child’s birth weight.
Relationships between Child Adipokines and Size (Birth
Weight and BMI) by Age
While child adiponectin levels at birth and birth weight were
unrelated (b=0.01, p= 0.47; r = 0.08), there was a progressively
significant negative association between adiponectin and BMI at 2
(b=22.91, p= 0.03; r =20.24), 5 (b=22.33, p = 0.01;
r =20.28), and 9 years (b=22.06, p,0.001; r =20.42)
(Table 2). Leptin levels at birth were associated with birth weight
(b=0.001, p,0.001; r = 0.46) and the leptin – BMI relationship
strengthened over the 2 (b=0.05, p,0.001; r = 0.52), 5 (b=0.07,
p,0.001; r = 0.73), and 9-year (b=0.09, p,0.001; r = 0.78) time
points.
Associations between Adipokine Levels at Different Ages
Crude bivariate analyses showed that while adiponectin levels at
birth were significantly but weakly associated with adiponectin at
older ages, stronger correlations were observed over the 2–5 and
5–9-year periods (Table 3). Additionally, strength of correlations
grew comparing birth – 2-years (b=0.14, p = 0.03; r = 0.25), 2–5-
years (b=0.38, p,0.001; r = 0.41), and 5–9-years (b=0.49,
p,0.001; r = 0.46). Leptin at birth did not significantly predict
later life leptin levels at either 2, 5, or 9 years. Leptin at 2 years was
weakly but significantly associated with leptin at both 5 (b=0.45,
p = 0.004; r = 0.31) and 9 (b=0.63, p = 0.05; r = 0.22) years. The
strongest correlation was found between 5 and 9-year-old leptin
levels (b=1.26, p,0.001; r = 0.62).
Description of Adipokine Trajectory Groups
Mixture modeling analysis identified three distinct trajectory
patterns for both adiponectin and leptin development over the
Figure 1. (A) Individual child adiponectin trajectories. Black rectangles indicate age at which adiponectin was measured. Orange, blue, and
green trajectories comprise groups 1A, 2A, and 3A, respectively, as identified by vertically-shifted mixture modeling (VSMM). (B) VSMM-defined
adiponectin trajectory groups. (C) Individual child leptin trajectories. Purple, orange, and dark blue trajectories comprise groups 1L, 2L, and 3L. (D)
VSMM-defined leptin trajectory groups.
doi:10.1371/journal.pone.0077964.g001
Childhood Adipokine Trajectories
PLOS ONE | www.plosone.org 4 October 2013 | Volume 8 | Issue 10 | e77964
birth – 9-year period (Figure 1). Adiponectin and leptin levels for
these groups across birth, 2, 5, and 9 years are described in
Table 4. P-values for differences across groups were not generated
as mixture modeling approaches estimate clustering through use of
posterior probabilities, assuming some amount of uncertainty in
group assignment. For adiponectin, groups were most separated
over the birth – 2-year period, with group 1A (N=19) having the
steepest decline in levels, group 2A (N= 31) showing a more
moderate decline and group 3A (N=30) showing the slowest
decline. At birth, mean6SD adiponectin levels for 1A, 2A, and 3A
were 155.7622.7 mg/ml, 117.5617.3 mg/ml and 80.8621.0 mg/
ml, respectively. These differences did not persist into older age,
with groups 1A, 2A, and 3A settling at a similar level over the 2–9-
year period. At 9 years, mean adiponectin levels for 1A, 2A, and
3A were relatively close, at 44.2620.6 mg/ml, 37.5615.8 mg/ml
and 46.7621.9 mg/ml, respectively. BMI at 2, 5, and 9 years and
waist circumference at 9 years were similar for 1A, 2A, and 3A
groups.
For leptin, groups 1L (N= 27) and 2L (N= 37) had similar rates
of decline from birth to 2 years. However, from 2 to 9 years, group
1L grew slowly while group 2L showed a rapid increase in leptin
levels. Group 3L (N= 16) showed minimal changes in leptin levels
over the birth – 9-year period. Mean6SD log(leptin) at birth for
1L, 2L, and 3L was 1.2860.28, 1.1160.34 and 0.6760.24,
respectively. At 9 years, leptin levels had decreased to 0.4860.26
for 1L, increased to 1.2960.29 for 2L, and stayed relatively
constant at 0.6360.22 for 3L. Compared to 1L and 3L, birth
weight, 2, 5, and 9-year BMI, along with 9-year waist circumfer-
ence, were all highest for the rapidly-rising 2L group. We found
only limited overlap in group membership comparing adiponectin
to leptin groups.
Associations between Early Life Factors and Adipokine
Groups
Our analysis examined whether candidate perinatal factors may
be associated with adipokine group membership, including
sociodemographics at pregnancy (maternal age, years in US,
education and family poverty category), child sex, gestational age,
birth weight, birth length, maternal pre-pregnancy BMI, gesta-
tional weight gain, and sugar-sweetened beverage consumption
during pregnancy (Table 5). Children with greater birth weight
had increased odds of belonging to the rapidly-rising 2L compared
to the reference 3L group (OR=1.21 95%CI 1.03, 1.43, per
100 gram increase). Additionally, children of mothers that
consumed more sugar-sweetened beverages during pregnancy
had increased odds of being in the steep-dropping and rebounding
1A compared to the reference 3A group (OR=1.08 95%CI 1.01,
1.17, per 1 drink/week increase). No other significant ORs were
found between the early life characteristics examined and
adipokine groups.
Discussion
In this study, we examined adiponectin and leptin development
in Mexican American children at high risk of obesity. To our
knowledge, this is the first time that adipokine trajectories have
been analyzed over the entire birth to 9-year period. While leptin
levels closely and positively reflected child body size at all ages,
adiponectin had inverse and weaker associations with BMI at 2, 5,
and 9 years. We identified three trajectory clusters for both leptin
(1L, 2L, and 3L) and adiponectin (1A, 2A, and 3A). Of the
perinatal factors examined, children with greater birth weight had
increased odds of belonging to the rapidly-rising group 2L and
those whose mothers consumed more sugar-sweetened beverages
during pregnancy were at risk of being in the steep-dropping
group 1A. Additionally, we found that correlations increased
comparing the birth – 2, 2–5, and 5–9-year periods for both
adiponectin and leptin. Taken together, our findings highlight the
different roles that adiponectin and leptin have during obesity
development in children and add evidence that perinatal factors
may have long lasting effects on metabolic health.
Our mixture modeling analyses identified key differences in
adiponectin compared to leptin development over time. For
adiponectin, we observed a large decrease in levels over the 0–2-
year period and suggest that this drop drives the heterogeneity in
child trajectories. On the other hand, for leptin, children tended to
be most separated over the 2–9-year period, with group 2L
children displaying a steady rise and increased BMI and waist
circumference at 9 years. We offer several reasons for these
observed differences in adipokine trajectories.
In our study, leptin levels were related closely to child birth
weight and BMI (Table 2) and, as a result, leptin trajectories are
likely to reflect child growth. Further highlighting this, Table 4
shows that children belonging to the rapidly-rising 2L group,
consistently had the highest birth weight and BMI at 2, 5, and 9
years. In fact, the leptin groups described here match closely in
shape the three BMI trajectories identified by Pryor et al, who
Table 4. Child adipokine levels and size by cluster.
Adiponectin Group
1A (N=19) 2A (N=31) 3A (N=30)
mean (SD) mean (SD) mean (SD)
A0 (mg/mL) 155.7 (22.7) 117.5 (17.3) 80.8 (21.0)
A2 (mg/mL) 42.4 (16.8) 59.2 (17.5) 48.8 (22.8)
A5 (mg/mL) 43.1 (17.5) 40.5 (15.9) 42.7 (21.8)
A9 (mg/mL) 44.2 (20.6) 37.5 (15.8) 46.7 (21.9)
Birth Weight (g) 3496 (537) 3447 (364) 3425 (455)
BMI2 (kg/m
2) 17.6 (1.3) 17.0 (1.9) 17.2 (1.7)
BMI5 (kg/m
2) 17.1 (1.5) 17.5 (2.9) 17.0 (1.9)
BMI9 (kg/m
2) 20.4 (3.6) 20.9 (4.3) 19.7 (4.1)
Waist9 (cm) 73.4 (10.0) 74.8 (12.1) 71.8 (11.5)
Leptin Group
1L (N=27) 2L (N=37) 3L (N=16)
mean (SD) mean (SD) mean (SD)
L0 1.28 (0.28) 1.11 (0.34) 0.67 (0.24)
L2 0.39 (0.15) 0.43 (0.17) 0.48 (0.14)
L5 0.36 (0.14) 0.59 (0.26) 0.48 (0.13)
L9 0.48 (0.26) 1.29 (0.29) 0.63 (0.22)
Birth Weight (g) 3494 (428) 3518 (432) 3219 (422)
BMI2 (kg/m
2) 16.5 (1.3) 17.6 (1.9) 17.5 (1.6)
BMI5 (kg/m
2) 16.0 (1.1) 18.4 (2.6) 16.6 (1.6)
BMI9 (kg/m
2) 17.3 (1.9) 23.3 (3.7) 18.5 (2.5)
Waist9 (cm) 64.9 (5.4) 81.4 (9.6) 68.9 (9.7)
A - adiponectin (mg/ml), L - log10(leptin).
BMI - body mass index. Waist - waist circumference.
A0, L0 - at birth, A2, L2 - at 2 years, A5, L5 - at 5 years, A9, L9 - at 9 years.
BMI9, Waist9 - at 9 years.
doi:10.1371/journal.pone.0077964.t004
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reported on low-stable, moderate and rapidly-rising BMI groups,
with the latter two indistinguishable over the 5-month to 2.5-year
period [2].
In contrast, although adiponectin was inversely associated with
BMI at 2, 5, and 9 years, these correlations were weaker compared
to those of leptin. Other factors that may affect adiponectin levels
over infancy remain poorly understood. Adiponectin is known to
play a critical role in insulin sensitivity, regulating glucose,
triglyceride and free fatty acid metabolism [6,34]. Given the
significant differences in pre and post-partum energy regulating
mechanisms, increasing energy requirements and changing body
composition during infant development, adiponectin levels may
more closely reflect these changes rather than of body size itself
[16,35,36]. Further supporting this interpretation, we and others
have previously shown that adiponectin is significantly related to
triglyceride and lipoprotein levels, independently of BMI in 9-
year-old children [19,37].
We did observe that group 1A had the steepest drop in
adiponectin levels and a slight rebound to higher values. Further,
children whose mothers had higher sugar-sweetened beverage
consumption had higher odds of belonging to this group.
Mechanisms responsible for this association remain unclear but
greater sugar-sweetened beverage consumption during pregnancy
may lead to increased glucose transfer to the fetus, resulting in
insulin-mediated effects on offspring adiponectin levels [38,39].
Nevertheless, the significance of this association should be
interpreted with caution, given that our data on maternal sugar-
sweetened beverage consumption were questionnaire-based and
may be subject to recall bias.
Importantly, it remains unclear whether there are long-term
health consequences for children in group 1A. We had lipid profile
data only on a small subset (N= 35) of the 80 children in this study
and our data showed that group 1A children tended to have higher
mean triglycerides (123.2 vs. 87.7mg/dL; N=9 and 12 respec-
tively), very low-density lipoproteins (24.7 vs. 17.6 mg/dL) and
lower high-density lipoproteins (46.4 vs. 55.1 mg/dL) compared to
group 3A. Despite the limited sample size, we suggest that children
with rapid adiponectin decreases over infancy may develop
adverse lipid levels and emphasize the need to further examine
possible metabolic consequences of early life changes in adipo-
nectin.
Additionally, we did observe that children with greater birth
weight had increased odds of being in the rapidly-rising 2L group.
This result is in line with several reports showing an association
between increased birth weight and membership to more rapidly-
rising BMI groups [1,3]. Previous studies have shown that children
born at either end of the birth weight spectrum are at higher risk of
obesity and metabolic disorders in adulthood [40–43]. In this
cohort, the majority of children were appropriate for gestational
age (N= 70) and our results further emphasize the important role
of birth weight in determining later life risk of obesity.
We also report that correlations increased comparing the birth –
2, 2–5, and 5–9-year periods for both adiponectin and leptin. Only
one study has previously examined these relationships for
adipokines, reporting no association for adiponectin and finding
a significant and positive association for leptin, comparing child
levels at birth and 3 years [17]. Our results are in agreement with
those from several other reports that focused on BMI, showing
that child BMI predicts adult obesity and this association
strengthens with child age [44,45]. Taken together, these data
may suggest greater plasticity during the early infancy period and
progressive constrainment to specific metabolic health with age.
Results of this study should be interpreted taking into account
several limitations. Our analyses were performed on a relatively
modest sample size of 80 children with complete adipokine data at
birth, 2, 5, and 9 years. Importantly, other than BMI and waist
circumference at 9 years, we had only limited data on children’s
lipid profile and no other measures of metabolic health. As a
result, consequences of the differing adiponectin trajectories
remain unclear. Additionally, we did not explicitly include onset
of puberty in our analyses. This may be an important factor to
consider given that both adiponectin and leptin are suppressed by
increased androgen release during puberty [46,47]. However, data
for our cohort show that child adiponectin, leptin and BMI did not
yet differ by sex at 9 years (Table S1). Finally, there may be
Table 5. Relationships between early life factors and adipokine group membership.
Adiponectin Group Leptin Group
1A1 2A 1L 2L
Early life characteristic mean (SD) N OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Gestational age (weeks) 38.8 (1.2) 80 1.14 (0.67, 1.96) 1.39 (0.83, 2.34) 1.48 (0.79, 2.79) 1.18 (0.66, 2.12)
Birth weight (100g) 34.5 (4.4) 80 1.02 (0.86, 1.2) 1.01 (0.87, 1.18) 1.35 (0.88, 2.08) 1.21 (1.03, 1.43)
Birth length (cm) 50.6 (2.5) 80 1.07 (0.82, 1.4) 1.03 (0.84, 1.27) 1.2 (0.89, 1.6) 1.21 (0.89, 1.64)
Maternal pre-pregnancy BMI (kg/m2) 26.5 (4.9) 80 1.1 (0.96, 1.27) 1.08 (0.84, 1.37) 0.98 (0.84, 1.14) 1.15 (0.96, 1.38)
Maternal gestational weight gain (kg) 14.3 (5.4) 80 0.99 (0.88, 1.13) 1.06 (0.93, 1.22) 1.08 (0.93, 1.26) 1.05 (0.9, 1.22)
Maternal SSB consumption (drinks/week) 14.3 (10.9) 79 1.08 (1.01, 1.17) 1.04 (0.97, 1.12) 0.89 (0.77, 1.03) 0.97 (0.92, 1.03)
OR - odds ratio, SD - standard deviation, BMI - body mass index, SSB - sugar-sweetened beverage.
1Odds ratios are calculated in reference to group 3 of either adiponectin (3A) or leptin (3L).
doi:10.1371/journal.pone.0077964.t005
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fluctuations in adipokine levels between the 0, 2, 5, and 9-year
time points not assessed by our analyses.
Strengths of this study include its extensive data collection, with
availability of biological samples, anthropometric measures and
questionnaire-based health assessments at a variety of time points.
Further, examining adipokine trajectories is particularly relevant
to the CHAMACOS population, given its high prevalence of child
obesity. It is also important to mention that the novel mixture-
modeling approach applied here helps improve our understanding
of adipokine development over childhood and obesity etiology in
general.
In conclusion, our results support the idea that children may be
on particular metabolic health trajectories from birth that become
progressively more defined with time. We identified several
potential risk factors for altered childhood adipokine levels,
including increased maternal sugar-sweetened beverage consump-
tion during pregnancy and increased child birth weight.
Additionally, our longitudinal data on adiponectin and leptin
highlight their different utilities, arguing that leptin remains tightly
linked to body size while adiponectin is more reflective of
underlying metabolic health during childhood.
Key future directions involve further exploring relationships
between the in utero environment and adipokine trajectories.
Additionally, while emerging data identify features of BMI growth
curves, such as increased BMI at infancy peak and early adiposity
rebound, as risk factors for later life obesity, the accompanying
changes in adipokine levels remain poorly understood [5]. Finally,
more research is needed to determine whether adipokine
trajectories over childhood can predict adolescent and adult
metabolic health.
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